Drug Trial Radar · NCT00102375
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer
Last checked: Nov 19, 2026Latest source record: Aug 4, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
900
Actual
Start
Dec 1999
Primary completion
Not stated
Study completion Oct 2004
Sponsor
- Lead sponsor
- AGO Study GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 31, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the triple combination of Carboplatin, Paclitaxel and Topotecan has a superior clinical outcome in the treatment of ovarian cancer compared with the combination of Carboplatin and Paclitaxel.
Conditions
- Ovarian Cancer
Interventions
TopotecanDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Gynecologic Hospital of the Medical Facilities RWTH
Aachen, Germany
Clinic for Gynecology and Gyn. Oncology, Humboldt University
Berlin, Germany
University Clinic Carl Gustav Carus, Gynecological hospital
Dresden, Germany
Gynecologic Hospital
Düsseldorf, Germany
University Gynecologic Hospital
Düsseldorf, Germany
University Gynecologic Hospital
Frankfurt, Germany
University Gynecologic Hospital
Göttingen, Germany
Gynecologic Clinic of the Ernst-Moritz-Arndt-University
Greifswald, Germany
Gynecological Clinic of the Medical University
Hanover, Germany
St. Vincentius Gynecologic Hospital
Karlsruhe, Germany
University Clinic Schleswig-Holstein, Campus Kiel, Clinic for gynecology and obstetrics
Kiel, Germany
Otto-von-Guericke University, University Gynecological Hospital
Magdeburg, Germany
University Gynecologic Hospital Grosshadern
München, Germany
University Gynecologic Hospital "rechts der Isar"
München, Germany
Clinic for Gynecology
Münster, Germany
University Gynecologic Hospital
Tübingen, Germany
University Gynecological Hospital
Ulm, Germany
Clinic for Gnyecology and gyn. Oncology HSK
Wiesbaden, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.